Bioventus Inc.BVSNASDAQ
Loading
Net Income ScalingExpanding
Percentile Rank100
5Y CAGR+6.7%
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

5Y CAGR
+6.7%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$22.73M+167.8%
2024$-33.54M+78.5%
2023$-156.23M+1.6%
2022$-158.70M-919.1%
2021$19.38M+18.1%
2020$16.41M+139.5%
2019$6.85M+156.1%
2018$-12.21M-644.8%
2017$-1.64M+90.9%
2016$-17.95M-